MMED (Minimed Group) Current Accrued Expense: $177 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MMED Minimed Group Inc MMED
15 GF Score
Price $19.85
! 3 Warning Signs
View Full Analysis

What is Minimed Group Current Accrued Expense?

Minimed Group MMED +1.77% 15 Current Accrued Expense is $177 Mil as of Apr. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 3 warning signs investors should review.

Minimed Group's Current Accrued Expense for the quarter that ended in Apr. 2026 was $177 Mil.

Minimed Group's quarterly Current Accrued Expense increased from Oct. 2025 ($128 Mil) to Jan. 2026 ($186 Mil) but then declined from Jan. 2026 ($186 Mil) to Apr. 2026 ($177 Mil).

Minimed Group's annual Current Accrued Expense increased from Apr. 2024 ($141 Mil) to Apr. 2025 ($300 Mil) but then declined from Apr. 2025 ($300 Mil) to Apr. 2026 ($177 Mil).

Minimed Group Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Minimed Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Current Accrued Expense Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25 Apr26
Current Accrued Expense
0.00 141.00 300.00 177.00

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26 Apr26
Current Accrued Expense Get a 7-Day Free Trial 0.00 300.00 128.00 186.00 177.00
MMED
15GF Score
Minimed Group Inc MMED
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $177 Mil mean?
Minimed Group (MMED) has a Current Accrued Expense of $177 Mil as of Apr. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Minimed Group and its competitors.
Is Minimed Group's Current Accrued Expense too high?
Minimed Group's current Current Accrued Expense is $177 Mil. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Current Accrued Expense compare to MMSI and NVST?
Minimed Group's Current Accrued Expense of $177 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Minimed Group and its competitors. Minimed Group's current Current Accrued Expense is $177 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Current Accrued Expense of $177 Mil. The current Current Accrued Expense is $177 Mil. Minimed Group's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Minimed Group (MMED), the current Current Accrued Expense is $177 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.85
Price